Marcello D Bronstein, MD, PhD

Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo
Papers:
Improvement of Biochemical Control in Patients with Acromegaly Switched from Octreotide LAR to Pasireotide LAR: Crossover Extension to a Double-Blind, Multicenter, Randomized, Phase III Study
Prolactinoma in childrens and adolescents: a retrospective study of presentation, management, and outcomes
Differential diagnosis of ACTH-dependent Cushing's syndrome: a case report
Malignant Pheochromocytoma in a Neurofibromatosis Type 1 Patient: A Case Report
Hyperprolactinemia exacerbated by testosterone replacement in a man with macroprolactinoma: The place of aromatase inhibitors
FP27-3 Inhibition of GH and IGF-1 Is Maintained with Pasireotide LAR and Octreotide LAR in Patients with Acromegaly: 12-Month Extension Phase of a Double-Blind, Multicenter, Randomized, Phase III Study
FP27-4 Pasireotide LAR and Octreotide LAR Normalize Prolactin Levels in Patients with Acromegaly and Hyperprolactinemia: Results from a Randomized, Double-Blind, 12-Month, Phase III Study
FP35-4 Association between the p27 V109G variant and tumor multiplicity in patients harboring MEN1 germline mutations